Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18220) 18220
Publication (1408) 1408
Book Review (151) 151
Book Chapter (56) 56
Magazine Article (55) 55
Book / eBook (52) 52
Newsletter (31) 31
Newspaper Article (24) 24
Conference Proceeding (17) 17
Dissertation (5) 5
Web Resource (3) 3
Reference (2) 2
Trade Publication Article (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16818) 16818
female (16263) 16263
adult (7486) 7486
middle aged (6823) 6823
index medicus (6810) 6810
oncology (5656) 5656
ovarian cancer (4943) 4943
ovarian neoplasms - pathology (4913) 4913
aged (4705) 4705
ovarian neoplasms - complications (4155) 4155
obstetrics & gynecology (4049) 4049
cancer (3975) 3975
ovarian neoplasms - surgery (3727) 3727
chemotherapy (2624) 2624
pregnancy (2412) 2412
surgery (2387) 2387
ovarian neoplasms - drug therapy (2240) 2240
carcinoma (2024) 2024
ovarian neoplasms - diagnosis (1983) 1983
male (1963) 1963
retrospective studies (1920) 1920
adolescent (1815) 1815
prognosis (1719) 1719
risk factors (1631) 1631
treatment outcome (1625) 1625
care and treatment (1617) 1617
neoplasm staging (1595) 1595
tumors (1572) 1572
ovarian-cancer (1564) 1564
research (1513) 1513
female genital diseases and pregnancy complications (1423) 1423
aged, 80 and over (1419) 1419
health aspects (1394) 1394
endocrine system diseases (1350) 1350
women (1292) 1292
survival (1269) 1269
obstetrics and gynecology (1253) 1253
diagnosis (1226) 1226
ovarian neoplasms - therapy (1133) 1133
ovarian neoplasms - genetics (1130) 1130
medicine & public health (1109) 1109
diagnosis, differential (1100) 1100
analysis (1086) 1086
animals (1066) 1066
antineoplastic combined chemotherapy protocols - therapeutic use (1060) 1060
ovarian neoplasms - mortality (987) 987
metastasis (977) 977
ovarian neoplasms (973) 973
young adult (968) 968
hematology, oncology and palliative medicine (959) 959
follow-up studies (929) 929
breast-cancer (928) 928
breast cancer (880) 880
child (879) 879
laparoscopy (871) 871
management (868) 868
combined modality therapy (849) 849
article (824) 824
ovarian neoplasms - metabolism (810) 810
pathology (810) 810
risk (803) 803
ovary (793) 793
hysterectomy (746) 746
cisplatin (742) 742
carcinoma, ovarian epithelial (740) 740
complications and side effects (722) 722
survival rate (707) 707
ovariectomy (703) 703
antineoplastic agents - therapeutic use (687) 687
paclitaxel (666) 666
cell line, tumor (659) 659
time factors (651) 651
ovarian neoplasms - epidemiology (643) 643
medicine, general & internal (638) 638
expression (637) 637
medicine (621) 621
ultrasonography (613) 613
immunohistochemistry (611) 611
prospective studies (604) 604
ovarian neoplasms - etiology (601) 601
disease-free survival (600) 600
gynecology (599) 599
research article (598) 598
patients (579) 579
neoplasms (576) 576
reproductive biology (574) 574
ovarian carcinoma (570) 570
mutation (561) 561
ovarian neoplasms - diagnostic imaging (560) 560
survival analysis (560) 560
cytoreductive surgery (558) 558
therapy (553) 553
mortality (552) 552
ovarian neoplasms - blood (546) 546
genetic aspects (541) 541
endometriosis - complications (536) 536
cancer therapies (534) 534
tomography, x-ray computed (518) 518
radiology, nuclear medicine & medical imaging (512) 512
development and progression (511) 511
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16165) 16165
French (492) 492
German (449) 449
Italian (210) 210
Spanish (195) 195
Polish (193) 193
Japanese (189) 189
Russian (181) 181
Chinese (83) 83
Dutch (37) 37
Bulgarian (35) 35
Czech (34) 34
Danish (34) 34
Portuguese (29) 29
Hungarian (25) 25
Serbian (17) 17
Turkish (17) 17
Croatian (16) 16
Korean (13) 13
Norwegian (12) 12
Finnish (11) 11
Romanian (11) 11
Hebrew (10) 10
Swedish (8) 8
Ukrainian (7) 7
Slovak (4) 4
Arabic (1) 1
Greek (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis
by Zhang, Z.‐J and Li, S
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2014, Volume 16, Issue 8, pp. 707 - 710
Aim Emerging evidence from epidemiologic studies and basic science suggests a potential antitumour effect of metformin. However, whether metformin improves... 
metformin | cancer | prognosis | survival | cancer‐specific survival | Prognosis | Cancer-specific survival | Metformin | Survival | Cancer | BREAST-CANCER | SURVIVAL | MORTALITY | THERAPY | COLORECTAL-CANCER | ENDOCRINOLOGY & METABOLISM | OVARIAN-CANCER | OUTCOMES | THIAZOLIDINEDIONES | CARCINOMA | CHEMOTHERAPY | Metformin - therapeutic use | Endometrial Neoplasms - mortality | Humans | Male | Antineoplastic Agents - therapeutic use | Diabetes Complications - diagnosis | Ovarian Neoplasms - mortality | Ovarian Neoplasms - complications | Colorectal Neoplasms - diagnosis | Colorectal Neoplasms - drug therapy | Endometrial Neoplasms - complications | Female | Ovarian Neoplasms - drug therapy | Colorectal Neoplasms - mortality | Hypoglycemic Agents - therapeutic use | Ovarian Neoplasms - diagnosis | Mortality | Diabetes Complications - drug therapy | Endometrial Neoplasms - diagnosis | Evidence-Based Medicine | Breast Neoplasms - drug therapy | Diabetes Complications - mortality | Breast Neoplasms - complications | Survival Analysis | Breast Neoplasms - mortality | Endometrial Neoplasms - drug therapy | Breast Neoplasms - diagnosis | Colorectal Neoplasms - complications | Care and treatment | Cancer patients | Endometrial cancer | Analysis | Hypoglycemic agents | Diabetes | Breast cancer | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
by Pearce, Celeste Leigh, Dr and Templeman, Claire, MD and Rossing, Mary Anne, Prof and Lee, Alice, MPH and Near, Aimee M, MPH and Webb, Penelope M, PhD and Nagle, Christina M, PhD and Doherty, Jennifer A, PhD and Cushing-Haugen, Kara L, MS and Wicklund, Kristine G, PhD and Chang-Claude, Jenny, Prof and Hein, Rebecca, PhD and Lurie, Galina, PhD and Wilkens, Lynne R, DrPH and Carney, Michael E, MD and Goodman, Marc T, Prof and Moysich, Kirsten, Prof and Kjaer, Susanne K, Prof and Hogdall, Estrid, PhD and Jensen, Allan, PhD and Goode, Ellen L, PhD and Fridley, Brooke L, PhD and Larson, Melissa C, MS and Schildkraut, Joellen M, Prof and Palmieri, Rachel T, MSPH and Cramer, Daniel W, Prof and Terry, Kathryn L, ScD and Vitonis, Allison F, SM and Titus, Linda J, Prof and Ziogas, Argyrios, PhD and Brewster, Wendy, PhD and Anton-Culver, Hoda, Prof and Gentry-Maharaj, Alexandra, PhD and Ramus, Susan J, PhD and Anderson, A Rebecca, BS and Brueggmann, Doerthe, MD and Fasching, Peter A, MD and Gayther, Simon A, Prof and Huntsman, David G, Prof and Menon, Usha, Prof and Ness, Roberta B, Prof and Pike, Malcolm C, Prof and Risch, Harvey, Prof and Wu, Anna H, Prof and Berchuck, Andrew, Prof and Ovarian Canc Assoc Consortium and Ovarian Cancer Association Consortium
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 4, pp. 385 - 394
Summary Background Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or... 
Hematology, Oncology and Palliative Medicine | HOSPITAL DISCHARGE DIAGNOSIS | PATHOGENESIS | WOMEN | ORIGIN | FERTILITY DRUGS | ONCOLOGY | INFLAMMATION | GENES | SUSCEPTIBILITY | INFERTILITY | CARCINOMA | Humans | Middle Aged | Risk Factors | Ovarian Neoplasms - pathology | Endometriosis - pathology | Ovarian Neoplasms - complications | Endometriosis - complications | Case-Control Studies | Ovarian Neoplasms - epidemiology | Ethnic Groups | Neoplasm Invasiveness - pathology | Aged, 80 and over | Female | Aged | Endometriosis - epidemiology | Neoplasm Staging | Women | Medical colleges | Oncology, Experimental | Psychotherapy | Family medicine | Endometriosis | Research | Risk factors | Ovarian cancer | Preventive health services | Prevention | Health aspects | Medicine, Preventive | Public health | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The role of the fallopian tube in the origin of ovarian cancer
by Erickson, Britt K., MD and Conner, Michael G., MD and Landen, Charles N., MD
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2013, Volume 209, Issue 5, pp. 409 - 414
Advanced cases of epithelial ovarian, primary peritoneal, and primary tubal malignancies have a relatively poor prognosis and collectively remain the most... 
Obstetrics and Gynecology | ovarian carcinogenesis | TP53 mutation | tubal intraepithelial carcinoma | GRADE SEROUS CARCINOMA | RISK | OOPHORECTOMY | INTRAEPITHELIAL CARCINOMA | MUTATIONAL ANALYSIS | ENDOMETRIOSIS | INCESSANT OVULATION | P53 | OBSTETRICS & GYNECOLOGY | WOMEN | EXPRESSION | Neoplasms, Glandular and Epithelial - pathology | Ovarian Neoplasms - prevention & control | Carcinoma in Situ - pathology | Humans | Carcinogenesis - genetics | Ovarian Neoplasms - pathology | Fallopian Tube Neoplasms - pathology | Neoplasms, Glandular and Epithelial - prevention & control | Carcinoma in Situ - complications | Genes, p53 | Carcinoma, Ovarian Epithelial | Genes, BRCA2 | Female | Fallopian Tube Neoplasms - complications | Genes, BRCA1 | Ovarian Neoplasms - etiology | Neoplasms, Glandular and Epithelial - etiology | Ovarian cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Impact of beta blockers on epithelial ovarian cancer survival
by Diaz, Elena S and Karlan, Beth Y and Li, Andrew J
Gynecologic Oncology, ISSN 0090-8258, 2012, Volume 127, Issue 2, pp. 375 - 378
Abstract Objective Stress may promote ovarian cancer progression through mechanisms including autonomic nervous system mediators such as norepinephrine and... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Adrenergic hormones | Beta blockers | Ovarian cancer | PATHWAYS | DEPRESSION | METASTASIS | CARCINOMA CELLS | ANGIOGENESIS | MECHANISMS | OBSTETRICS & GYNECOLOGY | BREAST-CANCER | ONCOLOGY | STRESS | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Multivariate Analysis | Humans | Middle Aged | Hypertension - drug therapy | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - mortality | Ovarian Neoplasms - complications | Peritoneal Neoplasms - complications | Peritoneal Neoplasms - drug therapy | Neoplasms, Glandular and Epithelial - mortality | Aged, 80 and over | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Ovarian Neoplasms - drug therapy | Adrenergic beta-Antagonists - therapeutic use | Ovariectomy | Peritoneal Neoplasms - surgery | Peritoneum - surgery | Treatment Outcome | Antihypertensive Agents - therapeutic use | Peritoneal Neoplasms - mortality | Neoplasms, Glandular and Epithelial - surgery | Neoplasms, Glandular and Epithelial - complications | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Hypertension - complications | Aged | Ovarian Neoplasms - surgery | Development and progression | Adrenergic beta blockers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort
by Zheng, Rui and Du, Mulong and Zhang, Baoguo and Xin, Junyi and Chu, Haiyan and Ni, Min and Zhang, Zhengdong and Gu, Dongying and Wang, Meilin
British Journal of Cancer, ISSN 0007-0920, 07/2018, Volume 119, Issue 1, pp. 130 - 132
Obesity is correlated with increased colorectal cancer (CRC) risk, but few studies have investigated lifetime body mass index (BMI) metrics and CRC risk. In a... 
POOLED ANALYSIS | OBESITY | ADULT WEIGHT CHANGE | ONCOLOGY | Overweight - complications | Humans | Middle Aged | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Weight Gain - physiology | Ovarian Neoplasms - complications | Overweight - epidemiology | Aged, 80 and over | Adult | Female | Body Mass Index | Colorectal Neoplasms - epidemiology | Prostatic Neoplasms - pathology | Overweight - pathology | Early Detection of Cancer | Obesity - complications | Risk Factors | Proportional Hazards Models | Lung Neoplasms - complications | Obesity - pathology | Ovarian Neoplasms - epidemiology | Prostatic Neoplasms - epidemiology | Lung Neoplasms - epidemiology | Obesity - epidemiology | Aged | Colorectal Neoplasms - complications | Prostatic Neoplasms - complications | Colorectal Neoplasms - pathology | Obesity | Body weight | Colorectal carcinoma | Colorectal cancer | Health risks | Risk | Medical screening | Body weight gain | Ovarian cancer | Confidence intervals | Body mass index | Life span | Body mass | Lungs | Body size | Trajectory analysis | Prostate | Cancer | Brief Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Pregnancy outcome in women with peritoneal, ovarian and rectovaginal endometriosis: a retrospective cohort study
by Vercellini, P and Parazzini, F and Pietropaolo, G and Cipriani, S and Frattaruolo, MP and Fedele, L
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 11/2012, Volume 119, Issue 12, pp. 1538 - 1543
Please cite this paper as: Vercellini P, Parazzini F, Pietropaolo G, Cipriani S, Frattaruolo M, Fedele L. Pregnancy outcome in women with peritoneal, ovarian... 
Endometriosis | placenta praevia | pregnancy | RISK | PREECLAMPSIA | OBSTETRICS & GYNECOLOGY | Pregnancy Complications - etiology | Endometriosis - surgery | Follow-Up Studies | Placenta Previa - etiology | Rectal Neoplasms - surgery | Humans | Peritoneal Neoplasms - surgery | Rectal Neoplasms - complications | Laparoscopy | Vaginal Neoplasms - surgery | Ovarian Neoplasms - complications | Endometriosis - complications | Peritoneal Neoplasms - complications | Incidence | Pregnancy | Placenta Previa - epidemiology | Adult | Female | Retrospective Studies | Vaginal Neoplasms - complications | Pregnancy Complications - epidemiology | Pregnancy Outcome | Cohort Studies | Ovarian Neoplasms - surgery | Hypertension | Pregnant women | Analysis | Oncology, Experimental | Research | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Molecular Profiling of Multiple Human Cancers Defines an Inflammatory Cancer-Associated Molecular Pattern and Uncovers KPNA2 as a Uniform Poor Prognostic Cancer Marker
by Rachidi, Saleh M and Qin, Tingting and Sun, Shaoli and Zheng, W. Jim and Li, Zihai
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e57911
Background: Immune evasion is one of the recognized hallmarks of cancer. Inflammatory responses to cancer can also contribute directly to oncogenesis. Since... 
BREAST-CANCER | METASTASIS | POLYMERIC IMMUNOGLOBULIN RECEPTOR | BIOMARKER | MULTIDISCIPLINARY SCIENCES | TISSUE | GENE-EXPRESSION | DOWN-REGULATION | KARYOPHERIN-ALPHA 2 | EPITHELIAL OVARIAN-CANCER | T-CELLS | Cell Adhesion Molecules - genetics | Colonic Neoplasms - genetics | Prognosis | Carcinoma, Squamous Cell - genetics | Humans | Gene Expression Regulation, Neoplastic | Databases, Genetic | Data Mining | Gene Expression Profiling | Inflammation - complications | Neoplasms - complications | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Neoplasms - genetics | Colonic Neoplasms - immunology | Adenocarcinoma - genetics | Colonic Neoplasms - mortality | Gene Expression | Adenocarcinoma - immunology | Neoplasms - mortality | Workflow | Inflammation - immunology | Carcinoma, Squamous Cell - immunology | Adenocarcinoma - complications | Colonic Neoplasms - complications | Head and Neck Neoplasms - immunology | Neoplasms - immunology | Carcinoma, Squamous Cell - complications | alpha Karyopherins - genetics | Inflammation - genetics | Head and Neck Neoplasms - complications | Head and Neck Neoplasms - genetics | Biomarkers, Tumor - genetics | Head and Neck Neoplasms - mortality | Neoplasm Staging | Adenocarcinoma - mortality | Cluster Analysis | Proteins | Immunohistochemistry | DNA microarrays | Analysis | Genes | Cancer | Ovarian cancer | Transcription factors | Ovarian carcinoma | Leukemia | Lung cancer | CXCL13 protein | Biochemistry | Genomes | Tissue analysis | Metastasis | Datasets | Liver cancer | Angiogenesis | Immunology | Colon cancer | Tumorigenesis | Colon | Neck | Protein transport | Pancreas | Bioinformatics | Immune system | Immunoglobulins | Head | Cytokines | Data processing | Inflammation | Breast cancer | CD36 antigen | Gene expression | Low level | Nuclear transport | Liquid oxygen | Biomarkers | Hypoxia | Molecular biology | Prostate | Prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, colorectal, and Ovarian cancer screening trial (PLCO)
by Sturgeon, Susan R and Pilsner, J.Richard and Arcaro, Kathleen F and Ikuma, Kaoru and Wu, Haotian and Kim, Soon-Mi and Chopra-Tandon, Nayha and Karpf, Adam R and Ziegler, Regina G and Schairer, Catherine and Balasubramanian, Raji and Reckhow, David A
Breast Cancer Research, ISSN 1465-5411, 08/2017, Volume 19, Issue 1, pp. 94 - 11
Background: Several studies have suggested that global DNA methylation in circulating white blood cells (WBC) is associated with breast cancer risk. Methods:... 
White blood cells | Breast cancer | Cohort | Global DNA methylation | 5mdC | SISTERS DISCORDANT | HYPERMETHYLATION | FAMILY REGISTRY | MARKER | MONONUCLEAR-CELLS | PERIPHERAL-BLOOD | HYPOMETHYLATION | NEW-YORK SITE | ONCOLOGY | EPIGENOME-WIDE ASSOCIATION | LUMA | Colorectal Neoplasms - genetics | Humans | Breast Neoplasms - etiology | Male | Leukocytes | Ovarian Neoplasms - complications | Ovarian Neoplasms - genetics | Prostatic Neoplasms - genetics | Prostatic Neoplasms - blood | Female | Breast Neoplasms, Male - epidemiology | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Lung Neoplasms - genetics | Colorectal Neoplasms - blood | Risk Factors | Ovarian Neoplasms - blood | Clinical Trials as Topic | DNA Methylation - genetics | Breast Neoplasms, Male - etiology | Lung Neoplasms - complications | Ovarian Neoplasms - epidemiology | Prostatic Neoplasms - epidemiology | Biomarkers, Tumor - blood | Lung Neoplasms - epidemiology | Breast Neoplasms - pathology | Neoplastic Cells, Circulating | Colorectal Neoplasms - complications | Lung Neoplasms - blood | Prostatic Neoplasms - complications | Breast Neoplasms, Male - pathology | Usage | Diagnosis | Health aspects | Risk factors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)
by Duska, Linda R and Java, James J and Cohn, David E and Burger, Robert A
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 139, Issue 2, pp. 221 - 227
Abstract Background Readmission within 30 days is a measure of care quality. Ovarian cancer patients are at high risk for readmission, but specific risk... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Chemotherapy | Readmissions | Ovarian cancer | 30-DAY HOSPITAL READMISSION | COLORECTAL SURGERY | PREDICTOR | SURGICAL CYTOREDUCTION | CANCER | CARE | OBSTETRICS & GYNECOLOGY | DISCHARGE | COST | ONCOLOGY | STAY | Multivariate Analysis | Peritoneal Neoplasms - blood | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - complications | Cytoreduction Surgical Procedures | Peritoneal Neoplasms - complications | Neoplasm, Residual | Fallopian Tube Neoplasms - blood | Peritoneal Neoplasms - drug therapy | Carcinoma - complications | Time Factors | Female | Neoplasms, Cystic, Mucinous, and Serous - drug therapy | Fallopian Tube Neoplasms - complications | Chemotherapy, Adjuvant | Carcinoma - pathology | Neoplasms, Cystic, Mucinous, and Serous - complications | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Body Mass Index | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Ascites - etiology | Carcinoma - blood | Neoplasms, Cystic, Mucinous, and Serous - pathology | Bevacizumab - administration & dosage | CA-125 Antigen - blood | Double-Blind Method | Obesity - complications | Risk Factors | Carboplatin - administration & dosage | Ovarian Neoplasms - blood | Fallopian Tube Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Cystic, Mucinous, and Serous - blood | Neoplasm Staging | Patient Readmission - statistics & numerical data | Medical research | Clinical trials | Medicine, Experimental | Risk factors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text More 'malignant' than cancer? Five-year survival following a first admission for heart failure
by Stewart, Simon and MacIntyre, Kate and Hole, David J and Capewell, Simon and McMurray, John J.V
European Journal of Heart Failure, ISSN 1388-9842, 6/2001, Volume 3, Issue 3, pp. 315 - 322
Background: The prognostic impact of heart failure relative to that of 'high-profile' disease states such as cancer, within the whole population, is unknown.... 
heart failure | epidemiology | cancer | prognosis | survival | population | Heart failure | Population | Prognosis | Epidemiology | Survival | Cancer | MORTALITY | FRAMINGHAM | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | PREVALENCE | TRENDS | DISEASE | OUTCOMES | DYSFUNCTION | Confidence Intervals | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Age Factors | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Patient Admission | Male | Scotland - epidemiology | Ovarian Neoplasms - mortality | Ovarian Neoplasms - complications | Neoplasms - complications | Life Expectancy | Aged, 80 and over | Female | Retrospective Studies | Heart Failure - epidemiology | Breast Neoplasms - epidemiology | Heart Failure - mortality | Heart Failure - complications | Neoplasms - mortality | Survival Rate | Lung Neoplasms - complications | Ovarian Neoplasms - epidemiology | Breast Neoplasms - complications | Myocardial Infarction - complications | Lung Neoplasms - epidemiology | Sex Factors | Survival Analysis | Breast Neoplasms - mortality | Aged | Neoplasms - epidemiology | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Paraneoplastic Thrombocytosis in Ovarian Cancer
by Stone, Rebecca L and Nick, Alpa M and McNeish, Iain A and Balkwill, Frances and Han, Hee Dong and Bottsford-Miller, Justin and Rupaimoole, Rajesha and Armaiz-Pena, Guillermo N and Pecot, Chad V and Coward, Jermaine and Deavers, Michael T and Vasquez, Hernan G and Urbauer, Diana and Landen, Charles N and Hu, Wei and Gershenson, Hannah and Matsuo, Koji and Shahzad, Mian M.K and King, Erin R and Tekedereli, Ibrahim and Ozpolat, Bulent and Ahn, Edward H and Bond, Virginia K and Wang, Rui and Drew, Angela F and Gushiken, Francisca and Collins, Katherine and DeGeest, Koen and Lutgendorf, Susan K and Chiu, Wah and Lopez-Berestein, Gabriel and Afshar-Kharghan, Vahid and Sood, Anil K
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 7, pp. 610 - 618
In patients with ovarian cancer and thrombocytosis, tumors may express interleukin-6, which stimulates production of thrombopoietin. The increase in platelets... 
MEDICINE, GENERAL & INTERNAL | ANGIOGENESIS | GROWTH | MICE | MODEL | INTERLEUKIN-6 | THROMBOPOIETIN | ASPIRIN | Blood Platelets - immunology | Interleukin-6 - antagonists & inhibitors | Humans | Antibodies, Monoclonal - therapeutic use | Ovarian Neoplasms - complications | Thrombopoietin - blood | Neoplasms, Glandular and Epithelial - blood | Interleukin-6 - blood | Female | Paraneoplastic Syndromes | Ovarian Neoplasms - drug therapy | Disease Models, Animal | Signal Transduction | Kaplan-Meier Estimate | Proportional Hazards Models | Ovarian Neoplasms - blood | Thrombocytosis - etiology | Thrombopoietin - antagonists & inhibitors | Mice, Knockout | Neoplasms, Glandular and Epithelial - complications | Disease-Free Survival | Animals | Platelet Count | Receptors, Interleukin-6 - deficiency | Interleukin-6 - immunology | Neoplasms, Glandular and Epithelial - drug therapy | Mice | Thrombocythemia | Usage | Medical examination | Blood platelets | Causes of | Thrombocytosis | Research | Diagnosis | Health aspects | Risk factors | Blood | Ovarian cancer | Animal models | Cytokines | Paracrine signalling | Data processing | Multivariate analysis | Patients | Thrombopoietin | Cell adhesion & migration | Interleukin 6 | Angiogenesis | Paclitaxel | Plasma levels | Platelets | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights